The pathological association between Down syndrome and Alzheimer disease - PubMed

Comparative Study

The pathological association between Down syndrome and Alzheimer disease

D M Mann. Mech Ageing Dev. 1988 May.

Abstract

The neuropathology of Down syndrome (DS) at middle age is compared with that of Alzheimer disease (AD) at that age, through a review of the published literature and from the author's personal observations on brains from a series of patients of different ages with DS. It is noted that the pathological changes of DS at middle age (i.e. the form and distribution of senile plaques and neurofibrillary tangles, the pattern of involvement (atrophy) of neuronal systems) are qualitatively the same as those of AD at that age, though quantitative differences do occur and these may relate to biological or sociological variations inherent to the two parent populations. It is concluded that in pathological terms patients with DS at middle age do indeed have AD. Some ways in which a study of patients with DS can give insight into the nature and development of the pathological changes of AD are put forward and discussed.

Similar articles

• Alzheimer's disease and Down's syndrome.

  Mann DM. Mann DM. Histopathology. 1988 Aug;13(2):125-37. doi: 10.1111/j.1365-2559.1988.tb02018.x. Histopathology. 1988. PMID: 2971602 Review.

• Neuropathology of Down syndrome and Alzheimer disease.

  Cork LC. Cork LC. Am J Med Genet Suppl. 1990;7:282-6. doi: 10.1002/ajmg.1320370756. Am J Med Genet Suppl. 1990. PMID: 2149963 Review.

• Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

  Wisniewski KE, Wisniewski HM, Wen GY. Wisniewski KE, et al. Ann Neurol. 1985 Mar;17(3):278-82. doi: 10.1002/ana.410170310. Ann Neurol. 1985. PMID: 3158266

• Down syndrome and Alzheimer disease.

  Hyman BT. Hyman BT. Prog Clin Biol Res. 1992;379:123-42. Prog Clin Biol Res. 1992. PMID: 1409740 Review.

• Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.

  Wegiel J, Flory M, Kuchna I, Nowicki K, Wegiel J, Ma SY, Zhong N, Bobrowicz TW, de Leon M, Lai F, Silverman WP, Wisniewski T. Wegiel J, et al. Acta Neuropathol Commun. 2022 Jan 4;10(1):2. doi: 10.1186/s40478-021-01300-9. Acta Neuropathol Commun. 2022. PMID: 34983655 Free PMC article.

Cited by

• Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-beta levels in female rats.

  Berry A, Tomidokoro Y, Ghiso J, Thornton J. Berry A, et al. Horm Behav. 2008 Jun;54(1):143-52. doi: 10.1016/j.yhbeh.2008.02.006. Epub 2008 Mar 10. Horm Behav. 2008. PMID: 18413150 Free PMC article.

• Polymorphisms in HSD17B1: Early Onset and Increased Risk of Alzheimer's Disease in Women with Down Syndrome.

  Lee JH, Gurney S, Pang D, Temkin A, Park N, Janicki SC, Zigman WB, Silverman W, Tycko B, Schupf N. Lee JH, et al. Curr Gerontol Geriatr Res. 2012;2012:361218. doi: 10.1155/2012/361218. Epub 2012 Mar 4. Curr Gerontol Geriatr Res. 2012. PMID: 22474448 Free PMC article.

• The promotion of physical activity for the prevention of Alzheimer's disease in adults with Down Syndrome: Rationale and design for a 12 Month randomized trial.

  Ptomey LT, Szabo-Reed AN, Martin LE, Mayo MS, Washburn RA, Gorczyca AM, Lepping RJ, Lee P, Forsha DE, Sherman JR, Danon JC, Donnelly JE. Ptomey LT, et al. Contemp Clin Trials Commun. 2020 Jun 30;19:100607. doi: 10.1016/j.conctc.2020.100607. eCollection 2020 Sep. Contemp Clin Trials Commun. 2020. PMID: 32642594 Free PMC article.

• Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

  Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL 3rd, Araoz C. Griffin WS, et al. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7611-5. doi: 10.1073/pnas.86.19.7611. Proc Natl Acad Sci U S A. 1989. PMID: 2529544 Free PMC article.

• Resting-State Functional Connectivity in Individuals with Down Syndrome and Williams Syndrome Compared with Typically Developing Controls.

  Vega JN, Hohman TJ, Pryweller JR, Dykens EM, Thornton-Wells TA. Vega JN, et al. Brain Connect. 2015 Oct;5(8):461-75. doi: 10.1089/brain.2014.0266. Epub 2015 Apr 28. Brain Connect. 2015. PMID: 25712025 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information